Gage Moreno

@[email protected]
140 Followers
106 Following
225 Posts
Postdoc at Harvard in Sabeti lab. Formerly O’Connor lab at UW-Madison. Interested in the genomic epidemiology, evolution, and pathogenicity of RNA viruses 🦠🏳️‍🌈
Twitterhttps://twitter.com/GageKMoreno
Personal Websitehttps://www.gagemoreno.com
Gage MorenoApr 18, 2023
RT @US_FDA
Today, FDA amended the EUAs of the Pfizer-BioNTech and Moderna COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-changes-simplify-use-bivalent-mrna-covid-19-vaccines
What you need to know. 🧵👇
Coronavirus (COVID-19) Update: FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines

The FDA amended the EUAs of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals.

U.S. Food and Drug Administration
Gage MorenoApr 9, 2023
“Nice day for a swim” - said only my dogs 🏊‍♂️🦮🐾
Gage MorenoApr 7, 2023
RT @mtwolfinger
Excited 2 share our new molecular epidemiology dataset for Yellow Fever virus on Nextstrain!🚀🔬🔍 With >1200 strains, including vaccine strains, this comprehensive dataset offers insights into genetic diversity, transmission patterns & evolution of #YFV https://nextstrain.org/groups/ViennaRNA/YFVnext
auspice

Gage MorenoApr 5, 2023

RT @NEJM
Maternal vaccination was 82% effective in preventing medically attended RSV-associated lower respiratory tract illness in infants within 90 days after birth and 69% effective within 180 days. Full results of the MATISSE trial: https://nej.md/3Mc1hmg

#InfectiousDisease

Gage MorenoApr 5, 2023

RT @MaryPetrone10
Very excited to see my last (fingers crossed) #COVID paper published in @GenomeBiolEvol! In this study, we took a trip down memory lane to investigate potential gaps in our genomic surveillance system.

Full text: https://doi.org/10.1093/gbe/evad052

Non-systematic reporting biases of the SARS-CoV-2 variant Mu could impact our understanding of the epidemiological dynamics of emerging variants

Abstract. Developing a timely and effective response to emerging SARS-CoV-2 Variants of Concern (VOCs) is of paramount public health importance. Global health s

OUP Academic
Gage MorenoApr 5, 2023

RT @NathanGrubaugh
@PanDengueNet Meeting in Lima, Peru - Nov 13-16, 2023

Now accepting abstracts. Due May 31

https://www.pandenguenet.org/submission-guidelines/

Submission and Guidelines 2023 – Pan American Dengue Research Network

Gage MorenoMar 31, 2023

RT @world_epidemic
We deep sequenced >2800 Covid-19 patients, including those with a breakthrough infection, to study minor variants.

We observe that:
1. VOCs tend to generate more minor variants.
2. Vaccination does not increase non-silent mutations.

Now in Nat Comm.
https://www.nature.com/articles/s41467-023-37468-y

Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals - Nature Communications

There is limited data on within-host SARS-CoV-2 genetic diversity and how it is affected by vaccination. The authors analysed intra-host sequence diversity and found that VOCs may have more sequence variations than non-VOCs and that breakthrough infections in vaccinated individuals do not seem to increase non-silent mutations.

Nature
Gage MorenoMar 24, 2023

RT @freemanjb
Update 🎉

NSF is taking a major step toward properly collecting data to improve LGBTQ+ equity in STEM. All PhD students in the US finishing in 2023-24 will be given LGBTQ+ questions in the survey required to graduate. Some concerns but almost there.

PDF: https://bit.ly/3LO5Z9I

Gage MorenoMar 24, 2023
RT @IDdocAdi
Trying to do your own stats for manuscript
Gage MorenoMar 21, 2023
Hey Boston people - go outside ☀️